Cytotoxic effect of hsp90 inhibitor radicicol in combination with cisplatin, doxorubicin, etoposide and 5-fluoro-2′-deoxyuridine on F4N cells

Comptes Rendus de L'Academie Bulgare des Sciences

Volumn 63, Issue 10, 2010, Pages 1471-1476

  Detcheva, Roumyana ^a   Pajpanova, Tamara ^a   Grancharov, Konstantin ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Bulgaria)

Author keywords

Cisplatin; Cytotoxicity; Doxorubicin; Etoposide and 5 fluoro 2spi_sup spii_sup deoxyuridine; Hsp90; Inhibitors; Radicicol

Indexed keywords

EID: 78249261515     PISSN: 13101331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Malloney A., P. Workman. Expert Opin. Biol. Ther., 2, 2002, No 1, 3-24.
2. Ochel H. J., C. Gademan. Onkologie, 25, 2002, No 5, 466-473.
3. Bagatell R., J. Beliakoff, C. L. David, M. T. Marron, L. Whitesell. Int.J. Cancer, 113, 2005, No 2, 179-188.
4. Neckers L., K. Neckers. Expert Opin. Emerg. Drugs, 7, 2002, No 2, 277-288.
5. Neckers L. Trends Mol. Med., 8, 2002, No 4, S55-S61.
6. Neckers L., K. Neckers. Expert Opin. Emerg. Drugs, 10, 2005, No 1, 137-149.
7. Schulte T., S. Akinaga, S. Soga, W. Sullivan, B. Stensgard, D. Toft, L. Neckers. Cell Stress Chaperones, 3, 1998, No 2, 100-108.
8. Gadelle D., M. Graille, P. Forterre. Biochem. Pharmacol., 72, 2006, No 10,1207-1216.
9. Spassovska N. C., P. R. Bonchev, K. C. Grancharov, E. V. Golovinsky. Method for synthesis of cis-diamminedichloroplatinum(II). Bulgarian Patent No 54667, 1981.
10. Detcheva R., K. Grancharov. Compt. rend. Acad. bulg. Sci., 59, 2006, No 10,1063-1066.
11. Fedier A., A. Stuedli, D. Fink. Int. J. Oncol., 27, 2005, No 6, 1697-705.